about
The role of cholinergic balance perturbation in neurological diseases.Acetylcholinesterase inhibitors and cholinergic modulation in Myasthenia Gravis and neuroinflammation.Number of evaluated lymph nodes and positive lymph nodes, lymph node ratio, and log odds evaluation in early-stage pancreatic ductal adenocarcinoma: numerology or valid indicators of patient outcome?Analysis of histological and immunological parameters of metastatic lymph nodes from colon cancer patients reveals that T-helper 1 type immune response is associated with improved overall survival.Modulation of inflammatory pathways by the immune cholinergic system.Optimal management of sarcomas of the breast: an update.Epithelial-to-mesenchymal transition (EMT) in intraductal papillary mucinous neoplasm (IPMN) is associated with high tumor grade and adverse outcomes.Adipose-Induced Retroperitoneal Soft Tissue Sarcoma Tumorigenesis: A Potential Crosstalk between Sarcoma and Fat Cells.Current management practice of breast borderline lesions--need for further research and guidelines.Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmine.Anti-inflammatory properties of cholinergic up-regulation: A new role for acetylcholinesterase inhibitors.T-Helper 1 Immune Response in Metastatic Lymph Nodes of Pancreatic Ductal Adenocarcinoma: A Marker For Prolonged Survival.Optimization of liposomal indocyanine green for imaging of the urinary pathways and a proof of concept in a pig model.Intraoperative Localization of Rectal Tumors Using Liposomal Indocyanine Green.Imaging the urinary pathways in mice by liposomal indocyanine green.C-reactive protein as a marker of complicated diverticulitis in patients on anti-inflammatory medications.IBU-octyl-cytisine, a novel bifunctional compound eliciting anti-inflammatory and cholinergic activity, ameliorates CNS inflammation by inhibition of T-cell activityCompletion surgery of residual disease after primary inadequate surgery of retroperitoneal sarcomas can salvage a selected subgroup of patients-A propensity score analysisSize and lipid modification determine liposomal Indocyanine green performance for tumor imaging in a model of rectal cancer
P50
Q36997158-E188D1AA-C999-4DF7-8ACC-154D4571E4FDQ37236598-739E75B4-5DF5-434E-B6E3-99C1031AA27CQ37294997-BBCC56C0-FFB6-44AA-90DF-BE9F9DC68BA8Q37409562-DB5720A6-F102-4D81-AC9B-E1585C043B59Q37970962-293F51AD-2472-4588-90D9-1A99E5D3366EQ38194594-FDBC54FA-2596-4078-A8F2-3055F316DE6CQ38305458-7BE1ACE1-B04B-4945-82BF-6FF76D06E673Q38746630-EA9D29BB-63F9-4D4F-BDD8-7BFFC1CCCFCEQ43735122-475BC9AE-669F-4178-B6DE-A7D2BC473E9EQ46436218-9EE68330-91AC-4826-8847-9EC731E75E11Q46841954-2C840E8C-21D4-4A76-B81C-A302BE0D3807Q47619850-6B93AC10-ECD6-42C4-8781-CAD41E52400CQ47831055-FADB870D-049B-4181-82D3-407B8719FC33Q50209045-F0623F87-E06F-4578-8CA7-F39B3E493C05Q50437844-6BA603B7-F61E-41DB-A021-2A7664536283Q50872299-0D90961E-1975-4D8C-A85F-53B26700B7B5Q80609376-E63EA87A-8889-4F09-A2E9-3506770E9C50Q90564401-B2227072-1619-4B03-B0A3-A70E2B6E9F60Q92691356-2C08A6FC-3DF6-4091-BC53-05514AEF274C
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Eran Nizri
@en
Eran Nizri
@nl
type
label
Eran Nizri
@en
Eran Nizri
@nl
prefLabel
Eran Nizri
@en
Eran Nizri
@nl
P31
P496
0000-0001-7935-2372